Impact of Incretin Mimetics on Thyroid Cancer Among Patients with Type 2 Diabetes: A Retrospective Cohort Time-to-Event Analysis

<b>Background</b>: Incretin mimetics, including glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonist) and dipeptidyl peptidase-4 (DPP-4) inhibitors, have been increasingly utilized for glycemic control in patients with type 2 diabetes (T2D). Studies have demonstrated additio...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael W. Strand, Daniel Chow, Weining Shen, Jonathan H. Watanabe
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Pharmacoepidemiology
Subjects:
Online Access:https://www.mdpi.com/2813-0618/4/2/9
Tags: Add Tag
No Tags, Be the first to tag this record!